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Psychiatric illness, such as affective disorders, anxiety disorders and schizophrenia, exerts exceptional personal burden on affected 
individuals. Although not physically noticeable, these disorders cost enormously on ones’ family and society. Currently pharma-
ceutical and psychological treatments are generally accepted as effective for psychiatric disorders, while the exact mechanisms 
underlying the treatment efficacy, etiology and neurobiology of the disorders remain elusive. In the past decade, “neurogenic hy-
pothesis” emerged as an attempt to explain the nature of psychiatric illness. The origination of the hypothesis is based on several 
pre-clinical and clinical observations. First, stress, which is a common risk factor of the disorders, was found to suppress neuro-
genesis; second, treatment for the illnesses like antidepressants and antipsychotics were shown to improve neurogenesis and be-
havioral deficits simultaneously; and third, the therapeutic effect of antidepressants was abolished in animal models when neuro-
genesis was blocked. Increasing efforts were invested to determine whether neurogenesis is a key to the understanding and treat-
ment of psychiatric disorders, although contrasting results are also found and thus the importance of neurogenesis remains a mat-
ter of debate. The present chapter will discuss the recent findings about the involvement of neurogenesis in major depression, 
anxiety disorders and schizophrenia, and whether neurogenesis would be a potential target for development of the treatment in the 
future. 
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According to a national epidemiology study of psychiatric 
conditions, the 12-month prevalence of psychiatric illnesses 
among Americans was over 26% [1], while the most com-
monly found diagnosis was anxiety disorder (18%) and is 
followed by mood disorders (9.5%). Different classes of 
psychiatric medications including antidepressants, anxiolyt-
ic drugs and antipsychotics are available for the treatment of 
mood, anxiety and schizophrenia disorders, respectively. 
Although medications have been used for decades, the exact 
mechanism of their therapeutic actions remains obscure. 
Furthermore, the psychopathology of the psychiatric ill-
nesses remains largely elusive. The limited understanding 
hampers the effectiveness of treatment and, consequently, 
enormous personal and societal burden are caused due to 
the diseases. Extraordinary effort was invested in disclosing 
the disease process, which aims at providing the theoretical 
basis for the development of more effective treatment 
methods [2].  
One of the brain regions being intensively studied for its 
involvement in psychiatric illness is the hippocampus [3]. 
The hippocampus is known for its involvement in learning 
and memory, cognitive function, mood regulation and re-
sponding to stress [4–6]. The function of hippocampus in 
learning and memory may be attributed to the presence of 
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new neurons produced throughout adulthood, namely, adult 
neurogenesis [7]. Neurogenesis is a process which involves 
neural progenitor cells production, migration, differentiation, 
maturation and functional integration into the existing cir-
cuit [8]. The discovery of proneurogenic effect of antide-
pressant [9] elicit the “neurogenesis hypothesis” of depres-
sion: due to the importance of hippocampus in mood regu-
lation and memory formation, the symptoms of depressive 
disorder are due to the decreased production of newborn 
neurons in hippocampus, and the therapeutic effect of anti-
depressants requires intact or enhanced neurogenesis [10]. 
In the past few years this hypothesis has been examined 
intensively from different perspectives, and current evi-
dence shows that the hypothesis may be partially true: neu-
rogenesis per se is not the sole cause of depressive disorder, 
while it is likely to be involved in psychiatric symptoms 
related to depression and the therapeutic effect of antide-
pressants [10]. Until now the hypothesis has been extended 
to other psychiatric illness such as schizophrenia and anxi-
ety disorders. Although increasing lines of evidence support 
the possible involvement of neurogenesis in psychiatric 
illness, further study is required before conclusion could be 
drawn. This review discusses recent studies which aimed at 
exploring the association between neurogenesis and three 
psychiatric conditions, including depressive disorders, schiz-
ophrenia and anxiety disorders. Our goal is to provide a 
better understanding of the roles of neurogenesis in the 
pathophysiology and treatment mechanism of the illnesses.  
1  Nurogenesisi: The process 
The term “neurogenesis” is a process which is defined as 
the ability of the precursor cells to generate functional neu-
rons within the central nervous system (CNS) [11]. This 
process has been previously believed to occur only during 
the embryonic development and the early postnatal period, 
but not in the adult CNS. However, Altman et al. [12] had 
provided the first evidence showing that new cells in ro-
dents can be generated within the subgranular zone (SGZ) 
of the dentate gyrus in the hippocampus. Later, a study from 
Paton et al. [13] had shown that new cells could be gener-
ated in the adult canary’s forebrain, which has further 
strengthened the possibility of adult neurogenesis and estab-
lished the theory that adult neurogenesis occurs primarily in 
two germinal zones: the subventricular zone (SVZ) of the 
dentate gyrus (DG) and the subgranular zone (SGZ). Apart 
from these two neurogenic regions, cell proliferation was 
reported to occur in other brain regions including neocortex, 
thalamus, hypothalamus, striatum and septum [14], but 
whether neurogenesis occurs remains controversial. Fur-
thermore, only SGZ neurogenesis is conclusively demon-
strated in the case of human.    
The process of adult neurogenesis within the hippocam-
pus and the subventricular zone can be briefly divided into 
four stages; they are (1) proliferation, (2) migration, (3) 
differentiation and (4) integration. Activation of the radial 
glia-like cells which reside in the SGZ within the dentate 
gyrus of the hippocampus can cause cell proliferation of the 
progenitor cells and in turn, the generation of the migrating 
neuroblasts. These cells are able to migrate from the SGZ to 
the outer granular layer which at this stage, the cells are 
termed immature neurons. These immature neurons can 
then be differentiated into dentate granule cells within the 
hippocampus. At a later stage, the dendrites gradually ex-
tend towards the molecular layer of the dentate gyrus with 
the establishment of synapses which can then integrate to 
the existing hippocampal-dependent neural circuit [11]. 
Very similar to the neurogenesis within the dentate gyrus, 
the activation of the radial glia-like cells which reside in the 
subventricular zone can cause proliferation of the transient 
amplifying cells and in turn, cause the generation of the 
migrating neuroblasts. However, at this stage, rather than 
migrating a short distance to the granular cell layer within 
the dentate gyrus, the immature neurons differentiate into 
neuroblasts within the subventricular zone and are able to 
migrate in a chain manner via the rostral migratory stream 
(RMS) pathway to the olfactory bulb. Upon the arrival to 
the olfactory bulb, maturation of the periglomerular neurons 
and granule cells will occur with synaptic formation which 
can be functionally integrated to the neural circuit of the 
olfactory system [11]. Other than the neuronal lineage, the 
progenitor cells within these regions can differentiate into 
glial cells, such as the progenitors derived from the hippo-
campus have been found to differentiate into oligodendro-
cytes and astrocytes in cell culture [2]. However, under 
physiological condition, a large majority of the cells derived 
from the neurogenic sites become neurons [2]. 
Kempermann et al. [15] suggested that in order to deter-
mine the functional significance of adult neurogenesis, three 
major components should be considered. They are the cel-
lular level, the network level and also the system level. For 
example, under physiological condition, the adult neuro-
genesis within the hippocampus was suggested to be in-
volved in the formation of trace memories [16]. Trace 
memory is defined as to associate events that occur in dif-
ferent times. In order to determine the functions of adult 
neurogenesis within the hippocampus, ablation of cells within 
the neurogenic site is a direct way to investigate its pro-
posed functions. Shors et al. [16] have shown that with the 
reduction of the new proliferating cells within the dentate 
gyrus by methyloxymethanol-actate, a DNA methylating 
agent, the hippocampal trace conditioning task could be 
impaired. However, with the recovery of the cells produc-
tion, an improvement of the ability to form trace memories 
was found. The functional significance of another neuro-
genic site, subventricular zone, has been currently related to 
sexual behaviors in rodents. Mak et al. [17] have shown that 
male pheromone can stimulate neurogenesis within the 
subventricular zone and the hippocampus of the female 
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mice. This leads to the hypothesis that the increase of neu-
rogenesis may be important for female reproductive success 
mediated by male pheromone. The importance of studying 
the subventricular zone and olfactory bulb neurogenesis is 
that olfaction is an important system for the survival of ro-
dents in the wild. In addition, rodents have been shown to 
highly rely on the pheromone signatures to determine their 
mates, which acts as a kind of selection in order to give fer-
tile offsprings [17]. The new cells generated from the sub-
ventricular zone are able to migrate for a long distance, via 
the RMS, to the olfactory bulb and differentiate into func-
tional neurons which are highly involved in the olfactory 
systems. Thus, the new neurons within the olfactory bulb 
provided from subventricular zone neurogensis is hypothe-
sized to be related to the rodent’s sexual behavior. This is 
further supported by evidence of animal’s behavioral test 
that following corticosterone treatment, cell proliferation in 
the subventricular zone was suppressed which was corre-
lated with alteration in male rodent’s sexual performance 
[18]. However, with antidepressant treatment using paroxe-
tine, cell proliferation in the subventricular zone, was in-
creased and sexual performance in male rodents was im-
proved [18]. Furthermore, the pro-sexual effect was abol-
ished when neurogenesis was blocked. The examples men-
tioned above have given the functional significance of adult 
neurogenesis within the dentate gyrus and the subventricu-
lar zone via investigating the changes of the cell number 
within the neurogenic sites and correlate this change with 
the animal behavioral tests as the functional readouts. 
2  Neurogenesis and depressive disorder 
Among different psychiatric disorders, depressive disorder 
is the first one to be associated with altered neurogenesis. 
Attention was paid to this potential linkage in past decades 
and this assumption remained controversial. The investiga-
tion was initially fueled by findings from several lines of 
evidence related to the pathophysiology and treatment of 
depression. First, stress, which is well accepted as a risk 
factor of depressive disorders and exacerbates mental dis-
orders, was shown to decrease neurogenesis in different 
animal studies [19]. Animal models of depressive disorders 
almost ubiquitously showed impaired neurogenesis in terms 
of both cell proliferation and survival [2]. Second, treatment 
of depression, such as different classes of antidepressants 
(e.g. SSRI and agomelatine [20,21]) and exercise, were 
shown to promote neurogenesis in animal models of de-
pression, Parkinson’s disease [22] or non-stressed, healthy 
animals [9,23]. Third, since the limbic circuit, which in-
cludes the hippocampus, is involved in affective behavior 
[24], new neuron production in the hippocampus was hy-
pothesized to take part in emotional processing. Based on 
these initial observations, it is proposed that the alteration of 
neurogenesis in the hippocampus may be the underlying 
cause of symptoms found in depressive disorders. This as-
sociation raised the interest in the research community, and 
the term “neurogenesis hypothesis of depression” was 
coined to describe the assumption of involvement of new 
neurons in the disorder [25]. The hypothesis postulates that 
the pathophysiology of depression is related to decrease in 
the production of newborn granule cells in the dentate gyrus, 
while promotion of the new neuron production could re-
verse the symptoms and is essential for the therapeutic ef-
fect of antidepressants [10].  
Despite the initial enthusiasm in elucidating the roles of 
neurogenesis in depression, later studies presented results 
which queried the assumed direct (or oversimplified) rela-
tionship between neurogenesis and depression. A clinical 
study which used post-mortem brain sections of major de-
pressive patients showed no significant difference in the 
number of hippocampal proliferating cells between normal 
controls and depressive patients [26]. However, due to ex-
perimental limitation in using human tissues, several aspects 
should be noted. One of the most important confronting 
factors is the lack of control on the medication history, in-
cluding antidepressants, of the patients. Since antidepressant 
may restore or enhance neurogenesis in the treated patients, 
this may mask the actual rate of neurogenesis in the depres-
sion state. Other aspects worth noting will be discussed later 
in this chapter. Nevertheless, this was the hallmark study 
which provided valuable data for human in vivo neurogene-
sis in depressive disease conditions. In contrast to this study, 
two recently published studies showed that antidepressant 
treatment in major depression patients increased the number 
of neural precursor cells and angiogenesis in the mid and 
anterior dentate gyrus [27]. The discrepancy between the 
two studies may be due to the use of different immuno-
chemical markers and quantification methods, which should 
be verified in future studies. Pre-clinically, suppression of 
neurogenesis in non-stressed animals did not result in in-
creased depression-like behavior [28,29], which denied the 
possibility that depressive disorder is caused by down-reg-     
ulation of hippocampal neurogenesis per se. Thus it is un-
likely that the symptoms of depression are caused solely by 
down-regulation of neurogenesis in human.  
Instead of causing depression-like behavior directly, neu-
rogenesis was shown to be required for the therapeutic ef-
fect of antidepressants in several animal studies. In a study 
conducted by Santarelli et al. [30], the consequence of neu-
rogenesis ablation was examined. X-irradiation was em-
ployed to specifically block the new neuron proliferation in 
the hippocampus of mice, which did not affect the cell divi-
sion of other body parts and systems. This technique de-
creased the cell proliferation up to 85% in the control ani-
mals. Then the animals were subjected to treatment of anti-
depressants chronically. With the antidepressant treatment, 
the sham-operated mice, as expected, showed a decreased 
latency to enter an anxiogenic area and exhibited a decreased 
latency in the novelty suppression test. In contrast, mice 
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with neurogenesis blocked did not show a decrease in la-
tency in both tasks. As the latency in both tests indicates the 
level of anxiety, it was concluded that the ablation of neu-
rogenesis prevented the anxiolytic effect of chronic antide-
pressant treatment. The result is particularly interesting be-
cause it showed that intact neurogenesis was required for 
the antidepressant to be effective. Another study utilized 
transgenic technology to illustrate the necessity of neuro-
genesis in rendering the effect of antidepressant [31]. Brain- 
derived neurotrophic factor (BDNF) is a neurotrophin in-
volved in neuronal survival, differentiation and proliferation 
[32]. Transgenic mice with the receptor for BDNF (receptor 
tyrosine kinase TrkB) being knocked out showed impaired 
neurogenesis. The neurogenesis was unable to be restored 
by antidepressant or exercise, which has been shown to be 
proneurogenic. Behaviorally, depression- and anxiety-like 
behavior could not be reduced by the treatments in the 
transgenic animals. In contrast, when the trkB expression 
was abolished in differentiated neurons but not neural pro-
genitor cells in the dentate gyrus, the animals showed re-
sponse to antidepressant treatment with increased neuro-
genesis and reduced depression-like behavior. The findings 
were further supported by other studies [28,33] which indi-
cate the lack of antidepressant or anxiolytic effect of psy-
chotropic drugs in the situation of neurogenesis blockage, and 
a slower recovery of hypothalamic-pituitary-adrenal-axis 
after stress was found in neurogenesis-deficient mice 
[34,35]. Collectively, although impaired neurogenesis alone 
did not cause depression-like behavior, it may abolish the 
therapeutic effect of antidepressants or sustain the state of 
depressive disorders.  
The neurogenesis process is regulated by different exter-
nal and internal factors. Since the neural progenitors are 
situated in a microenvironment of complex neural network, 
neurotransmitter plays a significant role in the regulation 
process. The neurotransmitter GABA was found to depo-
larize and promotes the differentiation of NPCs [36]. Sero-
tonin, which is originally associated with depressive disor-
der, is another neurotransmitter which regulates neurogene-
sis [37]. Direct stimulation of serotonin receptor 5HT(2B) 
promotes neurogenesis while inactivation of the receptor 
abolished the neurogenic and therapeutic effect of SSRI. 
Although there is lack of evidence to support the expression 
of NMDA receptors in hippocampal NPCs, glutamate was 
found to influence hippocampal neurogenesis [38], while 
the effect of dopamine and acetycholine depends on the type 
of receptors expressed in the hippocampus [39]. Apart from 
BDNF, other trophic factors including Vascular endothelial 
growth factor (VEGF) and insulin-like growth factor 1(IGF1) 
[40,41] also exhibit effect on neurogenesis. Infusion of both 
VEGF and IGF1 into the brain decreases depression/anxiety- 
like behavior and increases neurogenesis. Being similar to 
BDNF, the behavioral and cellular effect of VEGF is likely 
to be regulated by the cAMP-response element binding 
protein (CREB) with an elusive mechanism. Increasing 
lines of evidence suggest that the activation of immune sys-
tem may alter neurogenesis, although the results are still 
under debate. NF-kappa B (Nuclear factor kappa B) signal-
ing pathway, which is renowned for its involvement in in-
flammatory responses, was found to be activated by stress 
[42] and mediate the stress-induced depression-like behav-
iors and neurogenesis. Macrophage migration inhibitory 
factor (MIF, a pro-inflammatory cytokine) is a positive reg-
ulator of neurogenesis. MIF knock-out mice suffered from 
decreased neurogenesis and behavioral defects such as im-
paired hippocampal dependent memory and increased anxi-
ety-and depression-like behaviors [43]. In contrast, another 
pro-inflammatory cytokine interleukin 1beta was shown to 
be elevated in depression patients and decreased the number 
of newly proliferative cells in the hippocampus [44]. Lipo-
polysaccharide (LPS) is commonly used to mimic inflam-
mation and it was found that LPS treatment alone did not 
affect neurogenesis, rather it would abolish the antidepres-
sant effect of fluoxetine, a selective serotonin reuptake in-
hibitor (SSRI) [42]. From these results, it could be observed 
that inflammation or immunological responses are involved 
in the regulation of neurogenesis, while the precise action of 
each factor needs to be considered individually.  
Considering the neurogenesis hypothesis of depression, 
neurogenesis is altered in depressive disorder and evidence 
suggested that it is associated with depression. However, it 
is unlikely that depression is caused by impaired neurogen-
esis per se. Instead, the reduced neurogenesis may act as a 
limiting factor for antidepressants or other treatments to 
exert their effects. Thus neurogenesis may be another target 
of treatment due to its importance in mediating the effect of 
antidepressants. The disruption of hippocampal neurogene-
sis may contribute to symptoms related to hippocampal 
function like impaired working memory [45], which ration-
alize targeting neurogenesis when considering treatment for 
depressive patients. Tang et al. [46] suggested that the com-
plex changes in depression is caused by different intriguing 
factors, and neurogenesis may be merely one of them. Other 
factors related to cellular plasticity such as synaptogenesis, 
neuroinflammation and dendritic plasticity may be involved 
in depressive disorders and these factors still remain unclear 
in the study of neuropathology of depression [47]. Further-
more, as the majority of discoveries were found in pre- 
clinical situations, studies with human subjects or tissues 
will greatly facilitate the understanding of the issue [10]. 
Far more efforts will be required to elucidate the roles of 
neurogenesis in depressive disorders, and such insight will 
encourage future development of novel treatments.  
3  Neurogenesis and anxiety disorders 
Information regarding the involvement of neurogenesis in 
anxiety disorders was mainly generated from preclinical 
studies using animal models. The study of anxiety-like  
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behaviors in animals was originally related to animal mod-
els of depressive disorder. Application of stress is a direct 
cause of anxiety and it is widely considered as a risk factor 
of major depression and thus it is commonly used to estab-
lish animal models of depression. Despite the effort to study 
the relationship between neurogenesis and anxiety, several 
issues remain to be solved before a hypothesis regarding 
anxiety disorders and neurogenesis could be formulated. 
There is, surprisingly, still lack of clinical studies which 
examine neurogenesis in patients with anxiety disorders 
(including diagnosed generalized anxiety disorders, phobia 
and panic disorders) and this makes the significance of 
neurogenesis in these patients elusive. Another issue is that 
stressed animal models were usually used for the study of 
both anxiety and depression-like behaviors [48], which in-
dicates that the two types of behaviors are not usually 
clearly defined in experimental designs. Since depression- 
like behavior may interfere with anxiety-like behaviors and 
vice versa, the roles of neurogenesis in animal studies using 
anxiety models may be masked by depression-like behaviors.  
The association between neurogenesis and anxiety was 
suggested after Malberg et al. [9] discovered the proneuro-
genic effect of antidepressants as this class of medication 
was also used to treat anxiety disorders. As mentioned 
above, animal models used for the studies usually employ 
various types of stress to elicit anxiety responses, such as 
novelty-suppressed feeding (NSF) paradigm, unpredictable 
chronic mild stress (CMS) paradigm and social defeat test 
[30,49,50]. These tests induced stressful situations from 
behavioral or environmental measures and the variability of 
experimental conditions among different laboratories pro-
duced difficulties in the replication of results. In order to 
avoid this issue, several groups used exogenously applied 
corticosterone to induce anxiety-like behavior [18,51−53], 
since corticosterone is an adrenal hormone which is pro-
duced when the individual is under stressful situations such 
as restraint stress and exposure to predator. The dysfunction 
of the HPA-axis and hypercortisolemia found in depressive 
patients also support the application of corticosterone to 
simulate depressive/anxious state in animals [54,55]. In 
short, various animal models were used to study anxie-
ty-like behavior and this may be one of the causes of incon-
sistent findings across different studies.  
A hallmark study conducted by Santarelli et al. [30] in-
dicates the requirement of neurogenesis in therapeutic effect 
of antidepressants. In non-stressed mice, the latency to feed 
in NSF paradigm (which indicates the anxiety-like behavior) 
was decreased by chronic treatment of fluoxetine, which is 
associated with increased neurogenesis. When the dentate 
gyrus neurogenesis was ablated by X-irradiation, the anxio-
lytic effect of fluoxetine was abolished. Inspired by this 
finding, later studies examined whether the anxiolytic effect 
of antidepressants is neurogenesis dependent or independent. 
Contradictory results were found among different reports. 
HU210, a synthetic cannabinoid, exerts anxiolytic and anti-
depressant effects on animals while the effect was abolished 
if hippocampal neurogenesis was blocked [33]. In contrast, 
the anxiolytic effect of environmental enrichment and vol-
untary running was not affected by the blocking of neuro-
genesis [56]. Furthermore, the anxiolytic effect of a melanin- 
concentrating hormone receptor antagonist was found to be 
neurogenesis-independent while a recent study shows that 
pregabalin, an 2 ligand used for the treatment of neuro-
pathic pain and generalized anxiety disorders, prevented 
stress-induced depression-like behaviors and promotes the 
generation of neural precursor cells [57]. The discrepancy in 
the findings depends on the choice of behavior tests and 
method to abolish neurogenesis [51], in which forced swim-
ming test and open field test are neurogenesis independent 
while NSF and coat state are neurogenesis-dependent. As 
great differences between choice of stress model, method of 
blocking neurogenesis, behavioral testing and type of drugs 
used for treatment are commonplace, significance of neu-
rogenesis in anxiety and treatment effect requires further 
investigations.  
Unlike other anxiety disorders, post-trauma stress disor-
der (PTSD) was shown to associate with hippocampal neu-
rogenesis from clinical reports, although the number of re-
ports is still limited. Patients suffered from PTSD showed 
hippocampal atrophy and deficits in declarative verbal 
memory, which is related to hippocampus, while chronic 
treatment with paroxetine (a SSRI which increases neuro-
genesis [58,59]) could improve verbal declarative memory 
and reversed the hippocampal atrophy [60]. The effect of 
treatment for PTSD with another epileptic drug was  rep-
licated [61] in another study. From an animal study simu-
lating PTSD situation, inescapable shocks (IS) were applied 
on rats and PTSD-like (hypervigilant/hyperarousal) responses 
were elicited [62]. Hippocampal neurogenesis was decreased 
and it was correlated with the hyperactive behavioral pa-
rameters. Chronic SSRI treatment was able to rescue the 
decreased neurogenesis and decrease the hyperactive be-
havior simultaneously. Mechanistically, the disturbance of 
BDNF signaling in PTSD patients suggested a possible 
connection between neurogenesis and PTSD condition [63]. 
Although the data about the relationship between PTSD and 
neurogenesis seem to be promising, the hypothesis needs to 
be further confirmed by more in-depth pre-clinical and 
clinical studies.  
4  Neurogenesis and schizophrenia 
The association between schizophrenia and neurogenesis is 
supported by both clinical and pre-clinical reports. Accord-
ing to a post-mortem study conducted by Reif et al. [26], the 
density of Ki-67 (a nuclear antigen expressed by prolifera-
tive cells) in the dentate gyrus of schizophrenia patients was 
60% lower than that of control subjects. Surprisingly samples 
from bipolar disorder and major depression patients did not 
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show a significant lower cell density than the controls. This 
is the first clinical study which directly showed the altera-
tion of neurogenesis in schizophrenic patients. Although the 
result was clear and direct, there are several points that 
should be considered when interpreting the results. First, 
since Ki-67 expression is not restricted to proliferative cells 
of neuronal lineage, the Ki-67 quantification could not be 
directly interpreted as quantifying neuronal proliferation 
[64]. Glial cells such as astrocytes in the dentate gyrus may 
be quantified too. Second, the result only represented the 
initial stage of neurogenesis. As the majority of newly pro-
liferative neural precursor cells die before maturation, only 
a certain proportion of new neurons survives and becomes 
functional. Thus the later stages of neurogenesis (including 
survival, differentiation and integration into the neural cir-
cuit) should be investigated. Third, the result in the study 
was expressed as cell density. Since emotional disorder and 
schizophrenia were characterized by a reduction in hippo-
campal volume [64−67], the expression of result in terms of 
density could not show the absolute number of proliferative 
cells in samples being investigated.    
Being similar to depressive disorders, further evidence to 
support the link between neurogenesis and schizophrenia is 
provided by pre-clinical studies of pharmacological treat-
ments related to the disorder. Phencyclidine, a hallucino-
genic drug which induces symptoms similar to schizophre-
nia, reduces neurogenesis in animals [68]. Antipsychotics, 
in general, increase neurogenesis in animal models while 
the effect may be type and species-specific. Prototypic anti-
psychotic haloperidol promotes neurogenesis in the dentate 
gyrus of gerbils [69], while there is no effect in rats [70]. 
Atypical antipsychotics olanzapine and clozapine were also 
shown to increase neural stem cell proliferation in different 
regions including the dorsal striatum, hippocampus and pre-
frontal cortex [70−72]. Although other studies showed con-
tradictory results [73,74], the discrepancies may be due to 
animal species used, dosage of drug chosen, treatment re-
gime and route of administration. Thus the effect of anti-
psychotics on neurogenesis could not be ignored.  
An interesting finding that distinguishes schizophrenia 
from other psychiatric illness, in the view point of neuro-
genesis, is the existence of single genes susceptible to schiz-
ophrenia which are closely related to neurogenesis. One of 
the candidate genes under intensive investigation is DISC1 
(disrupted in schizophrenia 1) [75]. This gene was discov-
ered in a Scottish family with a large spectrum of psychiat-
ric disorders, and it is related to different traits including 
working memory, cognitive performance and gray matter 
volume. Genetic analysis and abnormal expression level in 
schizophrenic patients [73,74] support the strong linkage 
between DISC1 and schizophrenia. Interestingly, DISC1 is 
involved in several neuronal functions such as neuronal 
migration, neurite outgrowth and synaptic plasticity, which 
are essential processes in neurogenesis and neurodevelop-
ment [11,76]. In transgenic mice with Disc1 (mouse orthology 
of DISC1) mutation, working memory was decreased [77]. 
In the adult brain, down-regulation of Disc1 led to aberrant 
cell morphology, accelerated growth of axons and dendrites, 
ectopic location of new neurons [78], shorter dendrites and 
decreased surface area [79], and changes in the plasticity of 
mossy fiber/CA3 circuit [80]. Functionally, the immature 
neurons with low Disc1 expression showed exaggerated 
excitability and synaptic formation. These findings illustrate 
the significance of Disc1 in the process of neurogenesis, 
especially during the stage of integration of immature neu-
rons into the existing circuitry. Since Disc1 has different 
binding partners to exert its function, it is possible that mis-
regulation of the other binding proteins also contribute to 
the abnormal neurogenesis process, and contribute to the 
disease process [81].  
Recent studies disclosed the mechanism of neurogenesis 
regulation by DISC1. NMDA receptor, a receptor of gluta-
mate, is essential for proper newborn neuron migration and 
integration [82]. Memantine (a NMDA receptor antagonist) 
was shown to decrease the expression level of DISC1 and 
cause abnormal positioning of new neurons in the dentate 
gyrus, while overexpression of DISC1 could prevent the 
abnormalities. GABA-induced depolarization of neural pro-
genitor cells was recently found to be the pathway involved 
in DISC1 action [83], with convergence onto AKT (protein 
kinase B) pathway. DISC1 regulates depolarization induced 
by GABA signaling, which in turn controls the dendritic 
growth. When the time period of depolarization to hyperpo-
larization was accelerated, DISC1 loses the control of den-
dritic growth. In contrast, extension of this period allows 
DISC1 to regain regulation of dendritic growth. If DISC1 is 
suppressed, one of its binding partners KIAA1212 enhances 
activation of AKT, which leads to improper positioning and 
dendritic growth of newborn neurons. The defects could be 
prevented by the inhibition of an AKT downstream effector, 
mammalian target of rapamycin (mTOR) [84]. Taken to-
gether, the regulation of neurogenesis by DISC1 involves 
neurotransmitter such as GABA and glutamate, molecular 
switch such as AKT and mTOR and DISC1 binding part-
ners such as KIAA1212. The underlying mechanisms are 
being revealed, and further findings will definitely help to 
understand the regulation of neurogenesis, dendritic aberra-
tion in schizophrenia condition.  
Neuronal PAS domain-containing protein 3 (NPAS3) is 
another worth noting gene with susceptibility of schizo-
phrenia [85]. NPAS3 is a basic helix-loop-helix transcrip-
tion factor which was discovered in a family that suffered 
from schizophrenia [85]. Transgenic mice with NPAS3 muta-
tion showed a behavioral phenotype with reduced memory, 
impaired social recognition and impaired sensorimotor gat-
ing [86], which are also characteristics of schizophrenic 
patients. These animals simultaneously had a reduced neu-
rogenesis in the dentate gyrus [87]. Aminopropyl carbazole, 
which promotes neurogenesis by preventing apoptosis in the 
neurogenesis process, was able to increase neurogenesis and 
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reversed the malformation of dentate gyrus in NPAS3 
knock-out animals [86]. This suggests the proneurogenic 
property of NPAS3 lies on prevention of cell death but not 
proliferation. Further assessment of the association between 
NPAS3, neurogenesis and schizophrenia may provide an-
other possible target of future treatment.  
Another schizophrenia susceptibility gene is neuregulin 1 
(NRG1) [88]. This pleiotropic growth factor is important 
during neurodevelopment and functioning. If signaling path-
way of NRG1 is disturbed, N-meth7yl-D-aspartic acid 
(NMDA) receptor dysfunction may occur. This is hypothe-
sized to be the central mechanism underlying schizophrenia. 
The proneurogenic roles of NRG1 and neuregulin 2 (NRG2) 
were reported in the subventricular zone, while their roles in 
hippocampal neurogenesis remain to be determined [89]. 
Although not yet clear, NRG1 and NRG2 may also be in-
volved in neuron production in the dentate gyrus and the 
positive signs and symptoms of schizophrenia.  
As prenatal infection is a well accepted risk factor of 
schizophrenia, several research groups utilized an animal 
model of prenatal infection/maternal immune activation to 
study the involvement of neurogenesis in schizophrenia. 
Lipopolysaccharide (LPS) and polyriboinosinic-polyribo-        
cytidilic acid (polyI:C) were used to simulate bacterial and 
viral effects in pregnancy, and behavioral, chemical and 
cognitive changes are found in the animals, including dis-
ruption of prepulse inhibition, decrease in attention and 
working memory and responses to antipsychotic drugs 
[90,91]. The neurogenesis of the polyI:C treated offspring in 
adulthood was decreased [92], while co-treatment with 
risperidone could prevent such decrease [93]. These collec-
tively suggests that persistent changes in adult neurogenesis 
and cognitive functions could be induced by prenatal im-
mune challenge at early developmental stages, and the ma-
ternal immune activation models may provide interesting 
insight for the pathogenesis of schizophrenia.    
Although it is unlikely that schizophrenia is caused by 
single genetic disruption or mutation, the studying of sus-
ceptibility genes will illustrate different facets of the schiz-
ophrenia pathophysiology. Given that neurogenesis is closely 
associated with the candidate genes and disruption of neu-
rogenesis is found in clinical and pre-clinical reports, hy-
pothesis related to neurogenesis may provide a novel insight 
on the etiology and disease progress of schizophrenia. It is 
speculated that the altered neurogenesis may contribute to 
disrupted cognition, memory or social interaction in schizo-
phrenia, while these require further evidence to support [7].  
5  Amygdala and cortex: Non-traditional neu-
rogenic regions and relationship with psychiatric 
conditions 
The dentate gyrus of the hippocampus and the subventricular 
zone (SVZ) are the two well-accepted traditional regions 
which have the ability to produce new neurons in the adult 
brain. Several regions, such as the amygdala and the neo-
cortex, have been claimed to be the non-traditional neuro-
genic brain regions owing to the controversial results of their 
ability to produce new neurons in the adult brain [94−97]. 
Though the possibility of adult neurogenesis in these re-
gions is still under debate, studies on the cellular changes 
within the non-traditional neurogenic brain regions in rela-
tion to psychiatric illness should also be focused in addition 
to the vast majority of studies focusing on the traditional 
neurogenic sites. Just because the non-traditional neurogen-
ic regions, such as the amygdala and neocortex, also play an 
important role in mediating various psychological behaviors: 
social behaviors, reproductive behaviors, learning and 
memory [95]. The cellular changes within these regions 
may thus be highly related to the pathophysiology of the 
psychiatric disorder. 
Amygdala is one of the important structures within the 
limbic system and composed of different nuclei including 
basolateral, medial and central nuclei. These different parts 
of the nuclei responsible for different responses upon stim-
ulus from the environment and overall contribute to the so-
cial processes and emotions of individuals [98−100]. Re-
cently, a study reported that upon chronic social isolation of 
the female prairie voles from the main group could cause 
reduction in cell proliferation and alter neuronal differentia-
tion within the amygdala and similar results were obtained 
within the dentate gyrus of the hippocampus. These results 
support the fact that neurogenesis may be possible in the 
non-neurogenic site. Moreover, the reduction of the prolif-
erating cells in the amygdala seems to be associated with 
the behavioral changes. For example, the isolated female 
voles were found to have a higher anxiety level when com-
pared to the non-isolated group such that they have fewer 
entries to the center zone of the open-field test and a lower 
level of new cells was found concurrently within the amyg-
dala [96]. This report has provided evidence that new neu-
rons can be produced within the amygdala which is not one 
of the two neurogenic sites. In addition, the functional sig-
nificance of the cells found in the amygdala might link to 
regulating the anxiety upon the environment stimulus. Other 
than the decrease of neurogenesis in the amygdala can cause 
increase in the anxiety level, autism has also been hypothe-
sized to be related to neurogenesis in the amygdala [99]. 
Autism is a disorder in which the patients often show an 
unwillingness to have any social interactions [99,101]. 
Based on the observation on the morphological changes of 
the amygdala, it was found that there was a significantly 
decreased volume of the patients with autism [102]. The 
volume change of the amygdala may be due to decrease in 
neurogenesis or decreased in pruning of neurons [99,103]. 
Though some other controversial results have also shown, 
these results have given the possible relationship between 
the morphological changes of the amygdala and the patho-      
physiologic development of autism. Mercadante et al. [99]  
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Table 1  Summary of findings supporting the involvement of neurogenesis in psychiatric conditions  
 Animal study Clinical study Molecule/pathways involved 
Major depression -Stress (risk factor of depression): 
Suppress neurogenesis [30] 
-Antidepressants increases neuro-
genesis [9,23] 
-Intact neurogenesis required for 
treatment effect of antidepres-
sants and recovery of HPA axis 
[30,34] 
-Post-mortem brain study: Antide-
pressant treatment increase neuro-
genesis and angiogenesis [27] 
-Decrease in cortical gliogenesis 
associated with major depression 
[110,111] 
Growth factors: 
1) Brain-derived neurotrophic factor (BDNF) [31] 
2) Vascular endothelial growth factor (VEGF) [41] 
3) Insulin-like growth factor 1 (IGF1) [41] 
Neurotransmitters: 
1) GABA [36] 
2) Serotonin [37] 
3) Glutamate/NMDA receptor [38] 
4) Dopamine and acetylcholine [39] 
Immunoregulatory molecules: 
1) Macrophage migration inhibitory factor (MIF) [43] 
2) Nuclear factor kappa-light-chain-enhancer of ac-
tivated B cells (NF-B) [42] 
Anxiety Disorders -Animal models of anxiety disor-
ders: Show decreased neurogen-
esis [30,49] 
-Anxiolytic effect of antidepres-
sant depends on intact neurogen-
esis [30] 
-Pregabalin (Treatment for gener-
alized anxiety disorder) promote 
neurogenesis [57] 
-Animal model of PTSD: Show 
decreased neurogenesis [57] 
-PTSD patients: show hippocampal 
atrophy and deficits in hippocam-
pus-dependent verbal memory [63] 
Brain-derived neurotrophic factor (BDNF) [63] 
 
Schizophrenia -Phencyclidine (Hallucinogenic  
drug) suppress neurogenesis [68] 
-Antipsychotics increases neuro-
genesis [68] 
-Decrease in number of Ki-67 +ve 
cells in schizophrenia patients [26] 
Intracellular molecules: 
1) Disrupted in Schizophrenia 1 (DISC1) [75] 
2) Neuronal PAS domain protein 3 (NPAS3) [85] 
3) Neuregulin 1 (NRG1) [88] 
Neurotransmitters: 
1) Glutamate [82] 
2) GABA [83] 
Pathways: 
1) AKT/mTOR pathway [84] 
Immunoregulation [92] 
Other conditions  Autism patients: Decreased amyg-
dala volume, associated with de-
crease in amygdala neurogenesis? 
[99,103] 
 
 
have further suggested that the new immature-neurons 
newly produced in the amygdala may be helpful in increas-
ing the ability to learn from new experiences via modulation 
of the gamma-aminobutyric acid (GABA) as patients with 
autism were found to have alteration on the GABAergic 
system. However, further investigations are needed as this is 
a new etiologic hypothesis of autism. 
Neocortex is another non-traditional neurogenic region 
which has been highly debated about the existence of adult 
neurogenesis within this region. Gould et al. [104] was the 
first group to report that new neurons could be found in the 
adult primate using macaque monkeys. In addition, they 
have also suggested that the new neurons were from the 
subventricular zone and these migrating cells bypass the 
corpus callosum to reach the cerebral cortex [104]. There 
were some other studies supporting the above findings such 
that the new cells found within the neocortex of primates 
were originated from the subventricular zone, though under 
pathological conditions only, such as ischemia [105,106]. A 
recent study has shown that new cells could be found in 
layer I of the mice’s neocortex, though under ischemic con-
ditions. Further tracing the proliferating cells found in layer 
I of the neocortex with the membrane-targeted green fluo-
rescence proteins, these cells were shown to migrate to the 
other cerebral layers and further differentiate into GABAer-
gic neurons [107]. This study has suggested that neurogene-
sis may occur locally within layer I of the neocortex, but 
other origin of these new cells should not be excluded. 
However, the concept of neurogenesis within the adult ne-
ocortex has been challenged by many other groups. For 
example, Kornack et al. [108] have applied the injection of 
bromodeoxyuridine (BrdU) to trace the proliferating cells in 
macaque monkeys and found that none of the BrdU positive 
cells has double-labeled with the neuronal markers. Alt-
hough many studies have shown whether new cells could be 
found within the neocortex, there were only few studies 
focused on the functional significance of the new cells 
found in the neocortex and the possible relations with the 
psychiatric disorders. Compared to the cortical neurogenesis, 
gliogenesis seems to have more studies reporting about the 
changes of the glial cells within the neocortex and the pos-
sible role in relation with psychiatric disorders. For example, 
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depressive-like behaviors were found in adult rats using a 
pharmacologic glial ablation technique in the prefrontal 
cortex which suggested the possible role of the glial cells 
found in the prefrontal cortex in relation to depression [109]. 
Another example has shown that chronic stress could de-
crease cell proliferation in the medial prefrontal cortex 
which cause abnormal decrease in glial cells number [110]. 
According to some of the human studies, the decrease in the 
number of glial cells in the prefrontal cortex can trigger the 
development of various mood disorders [110,111]. Also, 
there was a study that found the reduction in glial density in 
the anterior cingulated cortex may be related to the major 
depressive disorder [111]. Glial cells have been previously 
suggested to retain the ability to renew in adult brains [110] 
and they have been shown to have important roles such as: 
regulating the process of synaptogenesis, adjusting the cer-
ebral flow and also lying very close to the neurons and the 
blood vessels for mediating the process of neurogenesis and 
angiogenesis [111]. Although neurogenesis is known to 
have an important role in relation to the psychiatric disor-
ders, the study on the gliogenesis within the adult brain 
should not be excluded particularly within the non-tradi-     
tional neurogenic sites.  
6  Conclusion 
Altered adult neurogenesis is widely observed in various 
animal models of psychiatric illnesses (Summarized in Ta-
ble 1). Ablation of neurogenesis reveals that neurogenesis 
could not explain the entire pathophysiology of different 
disorders, and the consequence of altered neurogenesis in 
the animal models requires further examination. While sup-
pression of neurogenesis is not a sufficient criterion for the 
development of depression, its association with schizophre-
nia and certain anxiety disorders begins to emerge from 
both clinical and pre-clinical studies. To further elucidate 
the roles of neurogenesis in psychiatric illnesses, clinical 
studies which assess the symptoms and functions related to 
traditional neurogenic zone (hippocampus and subventricu-
lar zone) and non-traditional neurogenic ones (e.g. amygda-
la and neocortex) are necessary, and development of stand-
ardized animal model/paradigm will be beneficial for solv-
ing the puzzle.  
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